# Molecular Targets for Cancer Detection and Treatment

> **NIH NIH T32** · JOHNS HOPKINS UNIVERSITY · 2020 · $605,841

## Abstract

PROJECT SUMMARY
 Since its inception, research-oriented academic training in oncology has been one of the top priorities of
the SKCCC. This training program provided opportunities for the trainees to apply fundamental scientific
methods to the study of the cellular and molecular biology of cancer, tumor and transplant immunology, molecular
virology, and the translation of the basic science discoveries to more effective cancer prevention, diagnosis, and
treatment. Over the years, the interdisciplinary research activities of the SKCCC have increased in size, scope,
and complexity with an emphasis on both clinical and basic scientific areas. The training opportunities have also
increased through the duration of this training grant. This training grant which has, in the past, provided a broad
training in cancer biology, pharmacology, chemotherapy, and immunology has for the past five years, focused
on providing training opportunities in the studies of genetic and epigenetic changes that are unique to cancer
cells and their possible use for cancer detection and therapy.
 The primary purpose of this grant is to train physician scientists in medical oncology in basic and
translational research in molecular targets for cancer detection and treatment. This training grant has been the
major support vehicle for the Center to provide an intensive research experience for physician trainees preparing
them to pursue careers in academic oncology. Although the opportunities for significant scientific advances have
dramatically increased, the number of physicians making a commitment to investigative careers in oncology is
diminishing. The training of physician scientists remains a critical need in today's scientific arena.
 To accomplish this goal, the individuals supported by this grant enter the program via the SKCCC's
Medical Oncology Fellowship Program. This fellowship program is offered as a three-year or more training
experience. The role of the Molecular Targets training program is to provide an intensive translational
research experience to selected medical oncology fellows in the second and third years of their medical
oncology fellowship. The goal in these three years of subspecialty training is to provide fellows with the skills
beyond the minimum required for subspecialty certification by the American Board of Internal Medicine as well
as to train a new generation of physician scientists. All but the first clinical year must be spent in full-time
research endeavors with the exception of the half day per week clinic requirement during the second year for
board eligibility purposes. The first clinical year and half day clinic is funded from clinical revenues or sources
other than this program. This training grant is the major mechanism for funding the subsequent research years
for physician scientist trainees. These fellowship experiences are highly sought after.

## Key facts

- **NIH application ID:** 9969064
- **Project number:** 5T32CA009071-40
- **Recipient organization:** JOHNS HOPKINS UNIVERSITY
- **Principal Investigator:** Mary Y Armanios
- **Activity code:** T32 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2020
- **Award amount:** $605,841
- **Award type:** 5
- **Project period:** 1979-09-15 → 2022-06-30

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/9969064

## Citation

> US National Institutes of Health, RePORTER application 9969064, Molecular Targets for Cancer Detection and Treatment (5T32CA009071-40). Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/grant/nih/9969064. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*